(Q51065265)

English

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.

scientific article published on 17 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease. (English)

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

cerebrospinal fluid

0 references

0 references

0 references

Robert Perneczky

3

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

author name string

Liang-Hao Guo

1

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

Panagiotis Alexopoulos

2

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

publication date

17 April 2013

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

European Archives of Psychiatry and Clinical Neuroscience

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

263

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

7

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

553-560

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

https://scigraph.springernature.com/pub.10.1007/s00406-013-0405-4

0 references

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Cerebrospinal fluid biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Multiple testing in disease mapping and descriptive epidemiology.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Evidence for ordering of Alzheimer disease biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Is the word 'biomarker' being properly used by proteomics research in neuroscience?

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Role and therapeutic potential of VEGF in the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Tissue-specific functions in the fatty acid-binding protein family

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Statistical significance for genomewide studies

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Fatty acid-binding proteins of nervous tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Alzheimer disease biomarkers are associated with body mass index

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

The role of proteomics in dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

The proteomic search for diagnostic biomarkers: lost in translation?

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease

2 references

https://api.crossref.org/works/10.1007%2FS00406-013-0405-4

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular dementia. Advances in nosology, diagnosis, treatment and prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of clinical diagnostic criteria for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of an ultra-rapid diagnostic method based on heart-type fatty acid binding protein levels in the CSF of CJD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00406-013-0405-4

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

1 reference

Europe PubMed Central

28 March 2018

http://europepmc.org/abstract/MED/23591828

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51065265&oldid=1533691306"